NCT05979779: An ongoing trial by Rivus Pharmaceuticals, Inc.
This trial is ongoing. It must report results 6 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05979779 |
|---|---|
| Title | A 6-Month, Randomized, Double-Blind, Placebo-controlled, Phase 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 5, 2023 |
| Completion date | Jan. 21, 2025 |
| Required reporting date | Jan. 21, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | July 7, 2025 |
| Days late | None |